Skip to Main Content

Author Details

Jeroen A C M Goos
Karolinska Institutet
2009
21
13
Emma Lundberg (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37552341Comparative in vivo biodistribution of cells labelled with [<sup>89</sup>Zr]Zr-(oxinate)<sub>4</sub> or [<sup>89</sup>Zr]Zr-DFO-NCS using PET.EJNMMI Res2023
35174429Correction: Optimisation of the Synthesis and Cell Labelling Conditions for [89Zr]Zr-oxine and [89Zr]Zr-DFO-NCS: a Direct In Vitro Comparison in Cell Types with Distinct Therapeutic Applications.Mol Imaging Biol2022
34231103Optimisation of the Synthesis and Cell Labelling Conditions for [<sup>89</sup>Zr]Zr-oxine and [<sup>89</sup>Zr]Zr-DFO-NCS: a Direct In Vitro Comparison in Cell Types with Distinct Therapeutic Applications.Mol Imaging Biol2021
32135473Design and preclinical evaluation of nanostars for the passive pretargeting of tumor tissue.Nucl Med Biol2020
31903138Delivery of polymeric nanostars for molecular imaging and endoradiotherapy through the enhanced permeability and retention (EPR) effect.Theranostics2020
33101778Expression of the immune modulator secretory leukocyte protease inhibitor (SLPI) in colorectal cancer liver metastases and matched primary tumors is associated with a poorer prognosis.Oncoimmunology2020
32250004pH-Responsive Polymers for Improving the Signal-to-Noise Ratio of Hypoxia PET Imaging with [<sup>18</sup> F]Fluoromisonidazole.Macromol Rapid Commun2020
31171598Temporal Modulation of HER2 Membrane Availability Increases Pertuzumab Uptake and Pretargeted Molecular Imaging of Gastric Tumors.J Nucl Med2019
30116191Biologically Targeted Magnetic Hyperthermia: Potential and Limitations.Front Pharmacol2018
25563886Glucose Transporter 1 (SLC2A1) and Vascular Endothelial Growth Factor A (VEGFA) Predict Survival After Resection of Colorectal Cancer Liver Metastasis.Ann Surg2016
26432753Molecular imaging of aurora kinase A (AURKA) expression: Synthesis and preclinical evaluation of radiolabeled alisertib (MLN8237).Nucl Med Biol2016
26497206A prognostic classifier for patients with colorectal cancer liver metastasis, based on AURKA, PTGS2 and MMP9.Oncotarget2016
27855440Loss of KCNQ1 expression in stage II and stage III colon cancer is a strong prognostic factor for disease recurrence.Br J Cancer2016
26172302MGL ligand expression is correlated to BRAF mutation and associated with poor survival of stage III colon cancer patients.Oncotarget2015
23975432The role of KCNQ1 in mouse and human gastrointestinal cancers.Oncogene2014
24983372Epidermal growth factor receptor (EGFR) and prostaglandin-endoperoxide synthase 2 (PTGS2) are prognostic biomarkers for patients with resected colorectal cancer liver metastases.Br J Cancer2014
23319175Combination of episulfide ring-opening polymerization with ATRP for the preparation of amphiphilic block copolymers.Macromol Rapid Commun2013
24104968Aurora kinase A (AURKA) expression in colorectal cancer liver metastasis is associated with poor prognosis.Br J Cancer2013
24002600Maspin is a marker for early recurrence in primary stage III and IV colorectal cancer.Br J Cancer2013
21677534SATB2 in combination with cytokeratin 20 identifies over 95% of all colorectal carcinomas.Am J Surg Pathol2011
19286549The initial stages of template-controlled CaCO3 formation revealed by cryo-TEM.Science2009
  • 1 - 21 of 21

Recommended Authors

Zhuhai People's Hospital (Zhuhai Hospital Affiliated with Jinan University)
Career Start Year 2013
Number of shared co-authors 0
Singapore General Hospital
Career Start Year 2010
Number of shared co-authors 0
The University of Texas MD Anderson Cancer Center
Career Start Year 2010
Number of shared co-authors 0
Roswell Park Comprehensive Cancer Center
Career Start Year 2010
Number of shared co-authors 0
University of North Carolina at Chapel Hill
Career Start Year 2009
Number of shared co-authors 0
Massachusetts General Hospital
Career Start Year 2008
Number of shared co-authors 0
Guangdong General Hospital, Guangdong Academy of Medical Sciences
Career Start Year 2007
Number of shared co-authors 0
Tisch Cancer Institute, Mount Sinai Hospital
Career Start Year 2005
Number of shared co-authors 0
The Johns Hopkins University School of Medicine
Career Start Year 2004
Number of shared co-authors 0
Maastricht University
Career Start Year 2004
Number of shared co-authors 0
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year 2003
Number of shared co-authors 0
Massachusetts General Hospital
Career Start Year 2002
Number of shared co-authors 0
Clinic for Gastroenterology, Medical University Hannover
Career Start Year 2001
Number of shared co-authors 0
Goldman School of Medicine, Ben Gurion University
Career Start Year 2001
Number of shared co-authors 0
University Health Network
Career Start Year 2001
Number of shared co-authors 0
University of Alabama at Birmingham
Career Start Year 2000
Number of shared co-authors 0
University of Texas MD Anderson Cancer Center
Career Start Year 2000
Number of shared co-authors 3
Institut fur Pathologie, Universitatsmedizin Mannheim
Career Start Year 2000
Number of shared co-authors 4
Royal College of Surgeons in Ireland (RCSI)
Career Start Year 1999
Number of shared co-authors 5
UF Health Cancer Center
Career Start Year 1998
Number of shared co-authors 1
Samsung Medical Center, Sungkyunkwan University School of Medicine
Career Start Year 1997
Number of shared co-authors 0
Hospital HM Universitario Sanchinarro
Career Start Year 1997
Number of shared co-authors 0
The First Affiliated Hospital of Xi'an Jiaotong University
Career Start Year 1997
Number of shared co-authors 0
Busan Paik Hospital, Inje University
Career Start Year 1996
Number of shared co-authors 0
University of Colorado Anschutz Medical Campus
Career Start Year 1995
Number of shared co-authors 1
Sichuan University
Career Start Year 1992
Number of shared co-authors 0
Cumming School of Medicine, University of Calgary
Career Start Year 1991
Number of shared co-authors 0
The Netherlands Cancer Institute
Career Start Year 1989
Number of shared co-authors 6
Case Western Reserve University
Career Start Year 1985
Number of shared co-authors 0
University of Colorado School of Medicine
Career Start Year 1974
Number of shared co-authors 1

Collaborators

The Netherlands Cancer Institute
Co-authored papers 11
The Netherlands Cancer Institute
Co-authored papers 10
Albert Schweitzer Hospital
Co-authored papers 4
The Netherlands Cancer Institute
Co-authored papers 3
Amsterdam University Medical Centers (Amsterdam UMC)
Co-authored papers 2
Skane University Hospital - Malmo, Lund University
Co-authored papers 1
Oncode Institute
Co-authored papers 1
AlbaNova University Center, KTH Royal Institute of Technology
Co-authored papers 1
KTH Royal Institute of Technology
Co-authored papers 1
Uppsala University
Co-authored papers 1
Princess Maxima Center for Pediatric Oncology
Co-authored papers 1
Uppsala University
Co-authored papers 1
UCD Conway Institute, University College Dublin
Co-authored papers 1
Co-authored papers 1
Uppsala University
Co-authored papers 1
UCD Conway Institute, University College Dublin
Co-authored papers 1
All-Island Cancer Research Institute, UCD Conway Institute, University College Dublin
Co-authored papers 1
UCD Conway Institute, University College Dublin
Co-authored papers 1
The Icelandic Cancer Registry
Co-authored papers 1
Co-authored papers 1
Oncode Institute
Co-authored papers 1
University of Minnesota
Co-authored papers 1
Princess Maxima Center for Pediatric Oncology
Co-authored papers 1
The Ottawa Hospital Cancer Centre
Co-authored papers 1
Karolinska Institute
Co-authored papers 1
Uppsala University
Co-authored papers 1
Breach Candy Hospital and Research Centre
Co-authored papers 1
Lund University
Co-authored papers 1
Skane University Hospital, Lund University
Co-authored papers 1
Lund University
Co-authored papers 1